What is the difference between “oncofertility” and “fertility preservation”? We find it important to use the term “oncofertility” because oncologists often don’t see themselves as fertility specialists. When we coined the term, […]
Cancer immunotherapy relies on getting T cells—the immune system’s primary killers of infected and diseased cells—to attack and kill tumor cells. But there’s an important stumbling block for immunotherapy: T cells’ ability to kill […]
The investigational drug selpercatinib may benefit patients with lung cancer whose tumors have alterations in the RET gene, according to preliminary results from a clinical trial. About 2% of patients with non-small cell lung cancer (NSCLC) […]
Immuno-oncology focusing on women’s cancers Technology Although cancer therapies have been developed that stimulate the immune system, these approaches have often proven ineffective because the cancers remain invisible to the immune system. […]
Technology CEL-SCI Corporation is a late-stage biopharmaceutical company developing products for life-threatening diseases (such as cancer and infectious diseases). Its lead pipeline product – Multikine investigational immunotherapy (Leukocyte Interleukin, Injection) is a […]
Two days of exceptional programming and networking anchored by 28 oncology companies. Attending investors heard insights from Jack Hidary Google Artificial Intelligence strategist provided insight on the future role of AI treating Cancer. Dr. […]
Cervical Cancer Cervical cancer continues to affect women of all ages worldwide. The disease often presents no symptoms in its early stages, which is why it is often referred to as a […]
Breast Cancer Breast cancer is the most common cancer in women worldwide, claiming the lives of hundreds of thousands of women each year. Although it’s rare, men can also be diagnosed with […]
